straddles and strangles Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : straddles and strangles

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: charlie mcgeehan who wrote (1)	8/16/2004 11:57:30 PM
From: charlie mcgeehan	of 10

i feel that possibly the best play this month is EYET. FDA will look at EYET new drug application on aug 27. this could really move the stock. hopefully we can have some discussion of this play as we approach the committee meeting day. The committee will discuss new drug application (NDA) 21–756, pegaptanib sodium injection (proposed tradename, Macugen) by Eyetech Pharmaceuticals, Inc., indicated for the treatment of exudative (wet) age-related macular degeneration.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next